Fall Reset is here! Free gift at $75+, 20% off at $150+, 30% off at $250+. - use code FALLRESET at checkout. Shop now →
,

CJC-1295 + Ipamorelin Blend

Price range: $65.00 through $150.00

Buy CJC-1295 (no DAC) + Ipamorelin blend research material — pairs a pulsatile GHRH(1-29) analog (CAS 863288-34-0) with a selective ghrelin-receptor (GHS-R1a) agonist (CAS 170851-70-4) for synergistic growth hormone secretagogue research. ≥97% HPLC purity. Research use only.

SKU: N/A Categories: ,

CJC-1295 + Ipamorelin Blend Research Material — Buy CJC-1295 (no DAC) / Ipamorelin (≥ 97% Purity)

This blend combines CJC-1295 without DAC (Modified GRF 1-29), a short-acting GHRH receptor agonist, with Ipamorelin, a selective ghrelin receptor (GHS-R1a) agonist. The two peptides act on distinct receptors that converge on pituitary somatotroph GH release, and are frequently co-administered in research settings to study synergistic (rather than merely additive) growth hormone secretagogue effects.

Mechanism of Action

CJC-1295 (no DAC) binds the GHRH receptor, a Gs-coupled class B GPCR, raising intracellular cAMP and driving PKA-mediated GH gene transcription and pulsatile release. Ipamorelin binds GHS-R1a, the ghrelin receptor, coupling to Gq/11 to activate phospholipase C-β and mobilize intracellular calcium, triggering a separate, complementary GH-release pathway with high selectivity (minimal ACTH/cortisol/prolactin co-release). Because the two peptides act through independent receptor systems that both converge on somatotroph GH exocytosis, combined administration is studied for synergistic amplification of the GH pulse relative to either peptide alone.

Research Applications

  • Synergistic dual-receptor (GHRH-R + GHS-R1a) growth hormone secretagogue research
  • Pituitary GH pulse amplitude and pulsatility studies
  • IGF-1 axis and downstream metabolic signaling research

Specifications

  • Components: CJC-1295 without DAC (Modified GRF 1-29) + Ipamorelin
  • CAS Numbers: CJC-1295 (no DAC) 863288-34-0; Ipamorelin 170851-70-4
  • CJC-1295 Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
  • Ipamorelin Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
  • Purity: ≥97% (HPLC verified, each component)
  • Form: Lyophilized powder blend
  • Available Sizes: 5mg / 5mg, 10mg / 10mg (CJC-1295 / Ipamorelin)

Storage & Handling

Store lyophilized blend at −20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 4°C and use within 28 days. All handling should be performed under sterile laboratory conditions by trained research personnel.

For in-vitro laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or medicinal product.

Size

10mg / 10mg, 5mg / 5mg

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 + Ipamorelin Blend”

Your email address will not be published. Required fields are marked *

Scroll to Top

Item added to cart

Continue shopping or proceed to checkout.

Continue Shopping Checkout
Stay Updated

Stay In The Loop

Sign up to hear about our latest promotions, new compounds, and product drops.

You’re Subscribed

You’re in!

Watch your inbox for our latest promotions and new product drops.

PureBond
Research Access Only

You're entering a restricted research compound store

PureBond supplies independently tested research materials exclusively to licensed researchers and authorized professionals. All products are sold strictly for in vitro and laboratory research purposes only and are not intended for human consumption, therapeutic use, or veterinary application.

Not a researcher? Exit this site